Wednesday, August 15, 2018 12:58:40 PM
Tikun was the first company to innovate and breed a high CBD low THC strain, “Avidekel,” which has been recognized internationally and dubbed the first “highless” marijuana strain by Reuters in 2012.
We conducted the world’s first and only successful Phase II clinical double blind study using cannabis as treatment for Crohn’s Disease and Colitis.
Tikun Olam draws on the knowledge of several of Israel’s top experts in research, cultivation, operations, and product development, including our own head of research, Professor Zvi Bentwich, who is a leading researcher in cannabis use for HIV/AIDS internationally, and Rafael Mechoulam, the "father of cannabis research."
https://tikunolamusa.com/about/
FEATURED ZenaTech, Inc. (NASDAQ: ZENA) First US Trial of IQ Nano Drone for Inventory Management • Oct 15, 2024 8:21 AM
Kona Gold Beverages, Inc. Announces Strategic Progress and Corporate Evolution • KGKG • Oct 15, 2024 9:00 AM
One World Products Secures First Order for Hemp-Based Reusable Containers, Pioneers Renewable Materials for the Automotive Industry • OWPC • Oct 15, 2024 8:35 AM
CBD Life Sciences, Inc. Announces Strategic MOU with U.S. Armed Forces for Groundbreaking Mushroom Supplement • CBDL • Oct 15, 2024 8:00 AM
HealthLynked Files Non-Provisional Patent for AI-Powered Healthcare Assistant, ARi • HLYK • Oct 15, 2024 8:00 AM
ZenaTech, Inc. (NASDAQ: ZENA) Launchs IQ Nano Drone for Commercial Indoor Use • HALO • Oct 10, 2024 8:09 AM